In recent staff movements, Stephanie Seidman has been announced as the latest addition to Womble Bond Dickinson’s patent team, serving as their newest partner. The firm, having offices in San Diego, California, released the news this Monday.
Seidman brings a wealth of expertise from her previous position at Dentons, where she guided clients in the biopharma sphere on the expansion and monetization of their patent portfolios. The extensive scope of her work includes patent prosecution, non-infringement and validity analyses, freedom-to-operate analyses, alongside IP due diligence during acquisition and funding operations. All these, according to the details supplied by Womble Bond Dickinson.
Seidman is not new to the rigors of the field; she has successfully drafted and prosecuted numerous patents in the pharmaceutical, biotechnical, and chemical sectors, a testament to her prowess and versatility in the patent field. This infusion of talent is expected to enhance Womble Bond Dickinson’s patent capabilities, particularly in the California region, divulged the firm.
For a more extensive coverage of the story, you can check Bloomberg Law Automation’s full article.